Foreign rare disease treatments start to enter Korea

It was confirmed foreign drug companies’ rare disease therapies or substances that are unknown to Korea were prepared to have clinical trials in Korea. It seems the movement has been led by the growth of the rare disease treatment market, which was globally spread for the past few years.

Based on the Ministry of Food and Drug Safety’s approval status of clinical trials, Chiltern International,...